286 related articles for article (PubMed ID: 27489104)
1. The Nuclear Protein IκBζ Forms a Transcriptionally Active Complex with Nuclear Factor-κB (NF-κB) p50 and the Lcn2 Promoter via the N- and C-terminal Ankyrin Repeat Motifs.
Kohda A; Yamazaki S; Sumimoto H
J Biol Chem; 2016 Sep; 291(39):20739-52. PubMed ID: 27489104
[TBL] [Abstract][Full Text] [Related]
2. DNA element downstream of the κB site in the Lcn2 promoter is required for transcriptional activation by IκBζ and NF-κB p50.
Kohda A; Yamazaki S; Sumimoto H
Genes Cells; 2014 Aug; 19(8):620-8. PubMed ID: 24948478
[TBL] [Abstract][Full Text] [Related]
3. Mapping the Interaction of B Cell Leukemia 3 (BCL-3) and Nuclear Factor κB (NF-κB) p50 Identifies a BCL-3-mimetic Anti-inflammatory Peptide.
Collins PE; Grassia G; Colleran A; Kiely PA; Ialenti A; Maffia P; Carmody RJ
J Biol Chem; 2015 Jun; 290(25):15687-15696. PubMed ID: 25922067
[TBL] [Abstract][Full Text] [Related]
4. Molecular modeling-based evaluation of dual function of IκBζ ankyrin repeat domain in toll-like receptor signaling.
Manavalan B; Govindaraj R; Lee G; Choi S
J Mol Recognit; 2011; 24(4):597-607. PubMed ID: 21472811
[TBL] [Abstract][Full Text] [Related]
5. The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators.
Dechend R; Hirano F; Lehmann K; Heissmeyer V; Ansieau S; Wulczyn FG; Scheidereit C; Leutz A
Oncogene; 1999 Jun; 18(22):3316-23. PubMed ID: 10362352
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of transcription by B cell Leukemia 3 (Bcl-3) protein requires interaction with nuclear factor κB (NF-κB) p50.
Collins PE; Kiely PA; Carmody RJ
J Biol Chem; 2014 Mar; 289(10):7059-7067. PubMed ID: 24459141
[TBL] [Abstract][Full Text] [Related]
7. Structure-function relationship of cytoplasmic and nuclear IκB proteins: an in silico analysis.
Manavalan B; Basith S; Choi YM; Lee G; Choi S
PLoS One; 2010 Dec; 5(12):e15782. PubMed ID: 21203422
[TBL] [Abstract][Full Text] [Related]
8. The N-terminal domain of IkappaB alpha masks the nuclear localization signal(s) of p50 and c-Rel homodimers.
Latimer M; Ernst MK; Dunn LL; Drutskaya M; Rice NR
Mol Cell Biol; 1998 May; 18(5):2640-9. PubMed ID: 9566883
[TBL] [Abstract][Full Text] [Related]
9. Identification of genes that elicit disuse muscle atrophy via the transcription factors p50 and Bcl-3.
Wu CL; Kandarian SC; Jackman RW
PLoS One; 2011 Jan; 6(1):e16171. PubMed ID: 21249144
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta.
Yamamoto M; Yamazaki S; Uematsu S; Sato S; Hemmi H; Hoshino K; Kaisho T; Kuwata H; Takeuchi O; Takeshige K; Saitoh T; Yamaoka S; Yamamoto N; Yamamoto S; Muta T; Takeda K; Akira S
Nature; 2004 Jul; 430(6996):218-22. PubMed ID: 15241416
[TBL] [Abstract][Full Text] [Related]
11. Detection of a ternary complex of NF-kappaB and IkappaBalpha with DNA provides insights into how IkappaBalpha removes NF-kappaB from transcription sites.
Sue SC; Alverdi V; Komives EA; Dyson HJ
Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1367-72. PubMed ID: 21220295
[TBL] [Abstract][Full Text] [Related]
12. Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas.
Mathas S; Jöhrens K; Joos S; Lietz A; Hummel F; Janz M; Jundt F; Anagnostopoulos I; Bommert K; Lichter P; Stein H; Scheidereit C; Dörken B
Blood; 2005 Dec; 106(13):4287-93. PubMed ID: 16123212
[TBL] [Abstract][Full Text] [Related]
13. Interaction of the C-terminal region of p105 with the nuclear localisation signal of p50 is required for inhibition of NF-kappa B DNA binding activity.
Matthews JR; Watson E; Buckley S; Hay RT
Nucleic Acids Res; 1993 Sep; 21(19):4516-23. PubMed ID: 7694229
[TBL] [Abstract][Full Text] [Related]
14. Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma.
Thornburg NJ; Pathmanathan R; Raab-Traub N
Cancer Res; 2003 Dec; 63(23):8293-301. PubMed ID: 14678988
[TBL] [Abstract][Full Text] [Related]
15. CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50.
Paz-Priel I; Cai DH; Wang D; Kowalski J; Blackford A; Liu H; Heckman CA; Gombart AF; Koeffler HP; Boxer LM; Friedman AD
Mol Cancer Res; 2005 Oct; 3(10):585-96. PubMed ID: 16254192
[TBL] [Abstract][Full Text] [Related]
16. Insulin receptor substrate-3, interacting with Bcl-3, enhances p50 NF-kappaB activity.
Kabuta T; Hakuno F; Cho Y; Yamanaka D; Chida K; Asano T; Wada K; Takahashi S
Biochem Biophys Res Commun; 2010 Apr; 394(3):697-702. PubMed ID: 20226764
[TBL] [Abstract][Full Text] [Related]
17. RelB-p50 NF-kappa B complexes are selectively induced by cytomegalovirus immediate-early protein 1: differential regulation of Bcl-x(L) promoter activity by NF-kappa B family members.
Jiang HY; Petrovas C; Sonenshein GE
J Virol; 2002 Jun; 76(11):5737-47. PubMed ID: 11992002
[TBL] [Abstract][Full Text] [Related]
18. C/EBPα, C/EBPα oncoproteins, or C/EBPβ preferentially bind NF-κB p50 compared with p65, focusing therapeutic targeting on the C/EBP:p50 interaction.
Dooher JE; Paz-Priel I; Houng S; Baldwin AS; Friedman AD
Mol Cancer Res; 2011 Oct; 9(10):1395-405. PubMed ID: 21813505
[TBL] [Abstract][Full Text] [Related]
19. Bcl-3 and NFkappaB p50-p50 homodimers act as transcriptional repressors in tolerant CD4+ T cells.
Grundström S; Anderson P; Scheipers P; Sundstedt A
J Biol Chem; 2004 Feb; 279(9):8460-8. PubMed ID: 14668329
[TBL] [Abstract][Full Text] [Related]
20. The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding.
Hatada EN; Nieters A; Wulczyn FG; Naumann M; Meyer R; Nucifora G; McKeithan TW; Scheidereit C
Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2489-93. PubMed ID: 1532257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
